The upregulation of transforming growth factor beta (TGF-β) in the fibroblast of the tumor microenvironment (TME) reduced effects of anti-PD-L1 inhibitors by restricting T-cell infiltration [29]. This evidence concerns the gene TGFB1 and neoplasm.